Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 5OTHER_GOV 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Cholangiocarcinoma 2Triple Negative Breast Neoplasms 1Sarcoma, Kaposi 1Prostatic Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Leukemia, Myeloid, Acute 1Breast Neoplasms 1

Interventions

Azacitidine 4fludarabine 3venetoclax 2bisantrene 2Cyclophosphamide 2Clofarabine 2vosaroxin 1treosulfan 1liposomal amphotericin B 1defactinib 1decitabine and cedazuridine drug combination 1cedazuridine 1cc-486 1Thalidomide 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Interleukin-2 1Idarubicin 1Human Papillomavirus Recombinant Vaccine nonavalent 1Filgrastim 1Everolimus 1Dexamethasone 1Decitabine 1Daunorubicin 1Dasatinib 1Cytarabine 1Cyclosporine 1Control Groups 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Leukemia, Myeloid, Acute × Everolimus × Clear all
NCT00636922 2013-02-15

Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia

Bayside Health

Phase 1 Unknown
40 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡